Medscape

Glucocorticoid injections into the infrapatellar fat pad do not reduce knee pain or effusion synovitis volume in patients with inflammatory […]

Given the FDA’s decision to initiate the removal of boxed warning labels from hormone therapy products, it may be prescribed

Findings underscore the risk for graded exercise in people with post-exertional malaise and point to careful activity pacing as a

A study evaluates the risk for osteoporosis or osteopenia associated with 5-alpha reductase inhibitors in women with two types of

Low physical activity in the morning and evening is linked to an increased death risk in adults with or at

Dr Teja Kapoor urges early-career clinicians not to underestimate Sjögren’s disease, which requires thorough testing and multidisciplinary collaboration. Medscape

Dr Teja Kapoor explores how cultural sensitivity and awareness can overcome barriers to timely Sjögren disease management in diverse communities.

Dr Teja Kapoor recalls a formative case to illustrate how early recognition and multidisciplinary care are transforming the management of

Cognitive impairment may affect nearly half of patients with systemic lupus erythematosus over the course of a year, with some

Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for severe outcomes,

Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; glomerulosclerosis predicts renal function

The Curbsiders recap their top clinical pearls of 2025. The Curbsiders

Starting metformin is associated with a lower risk of developing osteoarthritis over 11 years of follow-up in a study comparing

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also

Baricitinib offers a rapid and sustained control of disease activity in RA when using alone or with methotrexate, supporting effective

Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the very

A large US claims analysis links out-of-pocket medication costs with adherence and discontinuation patterns among patients with psoriasis or psoriatic

The first systematic study of gene variants and monoclonal antibody therapies found that even small changes in a target gene

Nearly 10 years after the first JAK inhibitor was approved for a dermatologic disorder, more uses are imminent, with fewer

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe treatment option and

Patients with indolent systemic mastocytosis exhibit a distinct vertebral fracture pattern, marked by a predominance of biconcave fractures, differentiating it

Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic antibody-associated vasculitis differ according to treatment

‘Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said

A report card on meeting goals of reducing activity and work limitations for people with arthritis delivers bleak news, but

How did some clinicians outside of private practice come to the dueling viewpoints that private practice is “dead” but that

Small-for-gestational-age births are more common among mothers with spondyloarthritis than in the general population; other adverse pregnancy outcomes are comparable.

New indication follows recent approval for idiopathic pulmonary fibrosis. Medscape Medical News